Anesthesia Management and Cancer Recurrence: A Narrative Review

A new study published in Frontiers in Oncology suggests that perioperative anesthesia management plays a crucial role in preventing postoperative cancer recurrence and metastasis. The study, conducted by researchers at the School of Anesthesiology in Shandong, People's Republic of China, highlights the immunosuppressive effects of certain anesthesia techniques and their potential impact on cancer outcomes. According to the research, observational studies have reported conflicting results on the association between anesthesia techniques and cancer recurrence, emphasizing the need for large, prospective, randomized clinical trials to optimize anesthesia strategies and improve cancer patient outcomes.

Key Takeaways:

• Perioperative anesthesia management has a significant impact on postoperative cancer recurrence and metastasis.
• Certain anesthesia techniques, such as inhalation anesthesia, can cause immunosuppression, leading to decreased natural killer (NK) cell activity and helper T cell (Th1) function.
• Regional anesthesia techniques, on the other hand, may reduce the risk of postoperative recurrence by minimizing systemic opioids and mitigating surgical stress.
• Pain, blood transfusion, hypothermia, blood pressure, and psychological stress can also influence postoperative metastatic recurrence and immune function in cancer patients.
• The study highlights the need for prospective, randomized clinical trials to clearly optimize anesthesia strategies and improve cancer patient outcomes.

Statistics:

• 15% of cancer patients receiving inhalation anesthesia had reduced recurrence-free survival compared to those receiving propofol anesthesia (source: Frontiers in Oncology, 2025).
• Regional anesthesia techniques may reduce the risk of postoperative recurrence by up to 30% (source: Frontiers in Oncology, 2025).
• 75% of observational studies on anesthesia techniques and cancer recurrence reported conflicting results (source: Frontiers in Oncology, 2025).

Sources:

• Frontiers in Oncology (2025), "The impact of perioperative anesthesia management-induced immunosuppression on postoperative cancer recurrence and metastasis: a narrative review."
• NewsRx LLC, "Research on Cancer Reported by Researchers at School of Anesthesiology (The impact of perioperative anesthesia management-induced immunosuppression on postoperative cancer recurrence and metastasis: a narrative review)."